Association of the pentanucleotide repeat polymorphism in NOS2 promoter region with susceptibility to migraine in a Chinese population

DNA and Cell Biology

Volumn 30, Issue 2, 2011, Pages 117-122

  Jia, Shasha ^a,b   Ni, Jianqiang ^b   Chen, Shougong ^a   Jiang, Yuting ^a   Dong, Wanli ^b   Gao, Yuzhen ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NUCLEOTIDE REPEAT; PENTANUCLEOTIDE REPEAT; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MICROSATELLITE REPEATS; MIGRAINE DISORDERS; NITRIC OXIDE SYNTHASE TYPE II; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC;

EID: 79551644129     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2010.1102     Document Type: Article

References (29)

1. Allen, R.C., Graves, G., and Budowle B. (1989). Polymerase chain reaction amplification products separated on rehydratable polyacrylamide gels and stained with silver. Biotechniques 7, 736-744.
2. Bä r, W., Brinkmann, B., Budowle, B., Carracedo, A., Gill, P., Lincoln, P., Mayr, W., and Olaisen, B. (1997). DNA recommendations. Further report of the DNA Commission of the ISFH regarding the use of short tandem repeat systems. International Society for Forensic Haemogenetics. Int J Legal Med 110, 175-176. (Pubitemid 27323768)
3. Bird, T.D., Jarvik, G.P., and Wood, N.W. (2001). Genetic association studies: genes in search of diseases. Neurology 57, 1153-1154.
4. Borroni, B., Rao, R., Liberini, P., Venturelli, E., Cossandi, M., Archetti, S., Caimi, L., and Padovani, A. (2006). Endothelial nitric oxide synthase (Glu298Asp) polymorphism is an independent risk factor for migraine with aura. Headache 46, 1575-1579.
5. Bredt, D.S. (1999). Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic Res 31, 577-596.
6. De Vries, B., Frants, R.R., Ferrari, M.D., and van den Maagdenberg, A.M. (2009). Molecular genetics of migraine. Hum Genet 126, 115-132.
7. Diener, H.C., Kü per, M., and Kurth, T. (2008). Migraine-associated risks and comorbidity. J Neurol 255, 1290-1301.
8. Fernandez, F., Lea, R.A., Colson, N.J., Bellis, C., Quinlan, S., and Griffiths, L.R. (2006). Association between a 19 bp deletion polymorphism at the dopamine beta-hydroxylase (DBH) locus and migraine with aura. J Neurol Sci 251, 118-123.
9. Gonzalez-Gay, M.A., Llorca, J., Sanchez, E., Lopez-Nevot, M.A., Amoli, M.M., Garcia-Porrua, C., Ollier, W.E., and Martin, J. (2004). Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain. Rheumatology (Oxford) 43, 1182-1185.
10. Griffiths, L.R., Nyholt, D.R., Curtain, R.P., Goadsby, P.J., and Brimage, P.J. (1997). Migraine association and linkage studies of an endothelial nitric oxide synthase (NOS3) gene polymorphism. Neurology 49, 614-617.
11. Headache Classification Subcommittee of the International Headache Society. (2004). The International Classification of Headache Disorders: 2nd edition. Cephalalgia 24 Suppl 1, 9-160.
12. Kawaguchi, Y., Tochimoto, A., Hara, M., Kawamoto, M., Sugiura, T., Katsumata, Y., Okada, J., Kondo, H., Okubo, M., and Kamatani, N. (2006). NOS2 polymorphisms associated with the susceptibility to pulmonary arterial hypertension with systemic sclerosis: contribution to the transcriptional activity. Arthritis Res Ther 8, R104.
13. Kun, J.F., Mordmü ller, B., Lell, B., Lehman, L.G., Luckner, D., and Kremsner, P.G. (1998). Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Lancet 351, 265-266.
14. Lea, R.A., Curtain, R.P., Shepherd, A.G., Brimage, P.J., and Griffiths, L.R. (2001). No evidence for involvement of the human inducible nitric oxide synthase (iNOS) gene in susceptibility to typical migraine. Am J Med Genet 105, 110-113.
15. Leung, T.F., Liu, E.K., Li, C.Y., Chan, I.H., Yung, E., Lam, C.W., and Wong, G.W. (2006). Lack of association between NOS2 pentanucleotide repeat polymorphism and asthma phenotypes or exhaled nitric oxide concentration. Pediatr Pulmonol 41, 649-655.
16. Liao, L., Lim, M.C., Chan, S.W., Zhao, J.J., and Lee, K.O. (2006). Nitric oxide synthase gene polymorphisms and nephropathy in Asians with Type 2 diabetes. J Diabetes Complications 20, 371-375.
17. Morris, B.J., Markus, A., Glenn, C.L., Adams, D.J., Colagiuri, S., and Wang, L. (2002). Association of a functional inducible nitric oxide synthase promoter variant with complications in type 2 diabetes. J Mol Med 80, 96-104.
18. Motallebipour, M., Rada-Iglesias, A., Jansson, M., and Wadelius, C. (2005). The promoter of inducible nitric oxide synthase implicated in glaucoma based on genetic analysis and nuclear factor binding. Mol Vis 11, 950-957.
19. Neufeld, A.H., and Liu, B. (2003). Comparison of the signal transduction pathways for the induction of gene expression of nitric oxide synthase-2 in response to two different stimuli. Nitric Oxide 8, 95-102.
20. Olesen, J. (2008). The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol Ther 120, 157-171.
21. Olesen, J., Thomsen, L.L., and Iversen, H. (1994). Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol Sci 15, 149-153.
22. Sjö strand, C., Modin, H., Masterman, T., Ekbom, K., Waldenlind, E., and Hillert, J. (2002). Analysis of nitric oxide synthase genes in cluster headache. Cephalalgia 22, 758-764.
23. Stam, A.H., van den Maagdenberg, A.M., Haan, J., Terwindt, G.M., and Ferrari, M.D. (2008). Genetics of migraine: an update with special attention to genetic comorbidity. Curr Opin Neurol 21, 288-293.
24. Stovner, L.J., Hagen, K., Jensen, R., Katsarava, Z., Lipton, R., Scher, A., Steiner, T., and Zwart, J.A. (2007). The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27, 193-210.
25. Toriello, M., Oterino, A., Pascual, J., Castillo, J., Colá s, R., Alonso-Arranz, A., Ruiz-Alegría, C., Quintela, E., Montó n, F., and Ruiz-Lavilla, N. (2008). Lack of association of endothelial nitric oxide synthase polymorphisms and migraine. Headache 48, 1115-1119.
26. Walsh, P.S., Metzger, D.A., and Higuchi, R. (1991). Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques 10, 506-513.
27. Warpeha, K.M., Xu, W., Liu, L., Charles, I.G., Patterson, C.C., Ah-Fat, F., Harding, S., Hart, P.M., Chakravarthy, U., and Hughes, A.E. (1999). Genotyping and functional analysis of a polymorphic (CCTTT)(n) repeat of NOS2A in diabetic retinopathy. FASEB J 13, 1825-1832.
28. Xu, W., Humphries, S., Tomita, M., Okuyama, T., Matsuki, M., Burgner, D., Kwiatkowski, D., Liu, L., and Charles, I.G. (2000). Survey of the allelic frequency of a NOS2A promoter microsatellite in human populations: assessment of the NOS2A gene and predisposition to infectious disease. Nitric Oxide 4, 379-383.
29. Xu, W., Liu, L., Emson, P.C., Harrington, C.R., and Charles, I.G. (1997). Evolution of a homopurine-homopyrimidine pentanucleotide repeat sequence upstream of the human inducible nitric oxide synthase gene. Gene 204, 165-170.